Suvizumab is an experimental antiviral drug and immunomodulator. It is a monoclonal antibody that binds to HIV-1.[1]
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | HIV-1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
References
edit- ^ "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. 23 (4). Geneva: World Health Organization: 344. 2009. ISSN 1010-9609.
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |